SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-241521
Filing Date
2019-09-10
Accepted
2019-09-10 07:39:09
Documents
13
Period of Report
2019-09-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d669980d8k.htm   iXBRL 8-K 25445
2 EX-99.1 d669980dex991.htm EX-99.1 12266
  Complete submission text file 0001193125-19-241521.txt   161705

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA itci-20190910.xsd EX-101.SCH 3111
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20190910_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20190910_pre.xml EX-101.PRE 10980
13 EXTRACTED XBRL INSTANCE DOCUMENT d669980d8k_htm.xml XML 3214
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 191084290
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1